Preliminary research show conolidine may inhibit unique ion channels, lessening neuronal excitability and limiting soreness indicators. This system is especially related in neuropathic soreness, exactly where irregular signaling results in persistent discomfort. Furthermore, conolidine seems to influence G protein-coupled receptor (GPCR) pathways i